Target engagement and drug residence time can be observed in living cells with BRET
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Target engagement and drug residence time can be observed in living cells with BRET
Authors
Keywords
-
Journal
Nature Communications
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-03
DOI
10.1038/ncomms10091
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NanoBRET—A Novel BRET Platform for the Analysis of Protein–Protein Interactions
- (2015) Thomas Machleidt et al. ACS Chemical Biology
- Deciphering the Cellular Targets of Bioactive Compounds Using a Chloroalkane Capture Tag
- (2015) Rachel Friedman Ohana et al. ACS Chemical Biology
- Application of BRET to monitor ligand binding to GPCRs
- (2015) Leigh A Stoddart et al. NATURE METHODS
- Prodrug Applications for Targeted Cancer Therapy
- (2014) Irene Giang et al. AAPS Journal
- Chemoproteomics Reveals Time-Dependent Binding of Histone Deacetylase Inhibitors to Endogenous Repressor Complexes
- (2014) Isabelle Becher et al. ACS Chemical Biology
- Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
- (2014) Rudolf Griss et al. Nature Chemical Biology
- The cellular thermal shift assay for evaluating drug target interactions in cells
- (2014) Rozbeh Jafari et al. Nature Protocols
- Tracking cancer drugs in living cells by thermal profiling of the proteome
- (2014) M. M. Savitski et al. SCIENCE
- Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing
- (2014) Datsen George Wei et al. PLoS Pathogens
- Structural basis for the design and synthesis of selective HDAC inhibitors
- (2013) Simone Di Micco et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands
- (2013) Georges Vauquelin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells
- (2013) Mikko Taipale et al. NATURE BIOTECHNOLOGY
- Determining target engagement in living systems
- (2013) Gabriel M Simon et al. Nature Chemical Biology
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate
- (2012) Mary P. Hall et al. ACS Chemical Biology
- Discovery and activity profiling of thailandepsins A through F, potent histone deacetylase inhibitors, from Burkholderia thailandensis E264
- (2012) Cheng Wang et al. MedChemComm
- Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapy
- (2012) Andrew J Wilson et al. Journal of Ovarian Research
- Setting Up a Bioluminescence Resonance Energy Transfer High throughput Screening Assay to Search for Protein/Protein Interaction Inhibitors in Mammalian Cells
- (2012) Cyril Couturier et al. Frontiers in Endocrinology
- Real-Time Imaging of Histone H4K12–Specific Acetylation Determines the Modes of Action of Histone Deacetylase and Bromodomain Inhibitors
- (2011) Tamaki Ito et al. CHEMISTRY & BIOLOGY
- Thailandepsins: Bacterial Products with Potent Histone Deacetylase Inhibitory Activities and Broad-Spectrum Antiproliferative Activities
- (2011) Cheng Wang et al. JOURNAL OF NATURAL PRODUCTS
- Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
- (2011) Marcus Bantscheff et al. NATURE BIOTECHNOLOGY
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Drug–target residence time: critical information for lead optimization
- (2010) Hao Lu et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis
- (2010) Roel H Wilting et al. EMBO JOURNAL
- Rebinding: or why drugs may act longerin vivothan expected from theirin vitrotarget residence time
- (2010) Georges Vauquelin Expert Opinion on Drug Discovery
- Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression
- (2010) T. Yamaguchi et al. GENES & DEVELOPMENT
- Quantitative determination of protein stability and ligand binding using a green fluorescent protein reporter system
- (2010) Morgane J. J. Moreau et al. Molecular BioSystems
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining
- (2010) Kyle M Miller et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- HaloTag-based purification of functional human kinases from mammalian cells
- (2010) Rachel Friedman Ohana et al. PROTEIN EXPRESSION AND PURIFICATION
- Direct comparison of bioluminescence-based resonance energy transfer methods for monitoring of proteolytic cleavage
- (2008) Helen Dacres et al. ANALYTICAL BIOCHEMISTRY
- Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin A
- (2008) Simon J. Crabb et al. BIOCHEMICAL PHARMACOLOGY
- Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function
- (2008) Peter J. Tummino et al. BIOCHEMISTRY
- Direct comparison of fluorescence- and bioluminescence-based resonance energy transfer methods for real-time monitoring of thrombin-catalysed proteolytic cleavage
- (2008) H. Dacres et al. BIOSENSORS & BIOELECTRONICS
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
- Evaluation of the Pharmacodynamic Effects of MGCD0103 from Preclinical Models to Human Using a Novel HDAC Enzyme Assay
- (2008) C. Bonfils et al. CLINICAL CANCER RESEARCH
- MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo
- (2008) M. Fournel et al. MOLECULAR CANCER THERAPEUTICS
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started